Last quarter (Q4 2022), Autolus Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Autolus Therapeutics's net income was $―. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 2.37M	$ 166.00K	$ 823.00K	$ 1.72M	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	$ 6.36M	$ 2.33M	-	-	-
Operating Expense	$ 134.13M	$ 173.89M	$ 166.65M	$ 169.86M	$ 141.96M	$ 25.01M
Operating Income	$ -131.76M	$ -167.53M	$ -164.32M	$ -168.15M	$ -141.96M	$ -25.01M
Net Non Operating Interest Income Expense	$ -5.17M	$ -7.20M	$ -843.00K	$ 536.00K	$ 2.54M	$ 660.00K
Other Income Expense	$ -4.21M	$ -1.52M	$ 821.00K	$ 1.35M	$ 412.00K	$ 1.10M
Pretax Income	$ -141.14M	$ -173.21M	$ -165.99M	$ -166.26M	$ -139.01M	$ -23.25M
Tax Provision	$ -19.25M	$ -24.37M	$ -23.89M	$ -24.16M	$ -15.16M	$ -2.60M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -121.89M	$ -148.84M	$ -142.10M	$ -142.09M	$ -123.85M	$ -20.65M
Basic EPS	$ -1.34	$ -1.57	$ -1.97	$ -2.76	$ -2.88	$ -0.52
Diluted EPS	$ -1.34	$ -1.57	$ -1.97	$ -2.76	$ -2.88	$ -0.52
Basic Average Shares	$ 273.09M	$ 94.99M	$ 72.08M	$ 51.56M	$ 43.07M	$ 39.37M
Diluted Average Shares	$ 273.09M	$ 94.99M	$ 72.08M	$ 51.56M	$ 43.07M	$ 39.37M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 134.13M	$ 173.89M	$ 166.65M	$ 169.86M	$ 141.96M	$ 25.01M
Net Income From Continuing And Discontinued Operation	$ -121.89M	$ -148.84M	$ -142.10M	$ -142.09M	$ -123.85M	$ -20.65M
Normalized Income	$ -121.89M	-	-	$ -142.09M	$ -120.19M	$ -20.65M
Interest Expense	$ 5.45M	-	-	$ 0.00	-	-
EBIT	$ -135.69M	$ -164.30M	$ -164.88M	$ -166.26M	$ -141.96M	$ -25.01M
EBITDA	$ -129.91M	$ -156.88M	$ -156.43M	$ -160.60M	$ -137.35M	$ -24.36M

Currency in USD

Autolus Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing